BioLife Solutions, Inc. $BLFS Shares Sold by Royce & Associates LP

Royce & Associates LP cut its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 40.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 371,154 shares of the medical equipment provider’s stock after selling 252,721 shares during the period. Royce & Associates LP owned approximately 0.76% of BioLife Solutions worth $14,419,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in BLFS. First Trust Capital Management L.P. bought a new position in shares of BioLife Solutions in the third quarter valued at $55,365,000. Dimensional Fund Advisors LP lifted its position in shares of BioLife Solutions by 1.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,035,757 shares of the medical equipment provider’s stock valued at $19,761,000 after acquiring an additional 10,587 shares during the last quarter. Bank of America Corp DE boosted its stake in shares of BioLife Solutions by 73.4% during the 1st quarter. Bank of America Corp DE now owns 904,103 shares of the medical equipment provider’s stock worth $17,250,000 after acquiring an additional 382,776 shares in the last quarter. Royal Bank of Canada boosted its stake in shares of BioLife Solutions by 8.1% during the 1st quarter. Royal Bank of Canada now owns 885,298 shares of the medical equipment provider’s stock worth $16,891,000 after acquiring an additional 66,010 shares in the last quarter. Finally, Granahan Investment Management LLC boosted its stake in shares of BioLife Solutions by 49.7% during the 1st quarter. Granahan Investment Management LLC now owns 722,057 shares of the medical equipment provider’s stock worth $13,777,000 after acquiring an additional 239,701 shares in the last quarter. 93.24% of the stock is currently owned by institutional investors.

BioLife Solutions Price Performance

BLFS stock opened at $38.61 on Tuesday. BioLife Solutions, Inc. has a 52-week low of $17.86 and a 52-week high of $39.76. The company’s 50 day simple moving average is $38.00 and its 200-day simple moving average is $28.72. The firm has a market capitalization of $1.89 billion, a P/E ratio of 33.28 and a beta of 1.82.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Zacks Research lowered BioLife Solutions from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 21st. Lake Street Capital downgraded BioLife Solutions from a “buy” rating to a “hold” rating and reduced their target price for the company from $33.00 to $31.00 in a report on Wednesday, July 22nd. Craig Hallum lowered BioLife Solutions from a “buy” rating to a “hold” rating and set a $31.00 price target for the company. in a research report on Wednesday, July 22nd. William Blair set a $31.00 price target on BioLife Solutions in a research report on Thursday, July 23rd. Finally, Benchmark cut BioLife Solutions from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. One equities research analyst has rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $31.38.

View Our Latest Analysis on BLFS

About BioLife Solutions

(Free Report)

BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials. The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.

Recommended Stories

Want to see what other hedge funds are holding BLFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report).

Institutional Ownership by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.